DRUG DISCOVERY SOFTWARE MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST

  2024-10-30 |   Pages: 200+ |   Report ID: BYR-198065 |   Technology

Historical data: 2018 - 2023

Forecast period: 2024 - 2031

Quantitative units: Revenue in USD million and CAGR from 2024 to 2031

Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Drug Discovery Software Market

Image

1.1 SCOPE OF THE REPORT

1.2 MARKET SEGMENT ANALYSIS

1.3 REGULATORY SCENARIO BY REGION/COUNTRY

1.4 MARKET INVESTMENT SCENARIO STRATEGIC

1.5 MARKET ANALYSIS BY TYPE (USD MILLION)

1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)

2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS

  2.1.1 MARKET DRIVER ANALYSIS

  2.1.2 MARKET RESTRAINT ANALYSIS

  2.1.3 MARKET OPPORTUNITY

  2.1.4 MARKET CHALLENGES

3.1 INDUSTRY TRENDS

  3.1.1 SWOT ANALYSIS

  3.1.2 PESTEL ANALYSIS

  3.1.3 PORTER’S FIVE FORCES ANALYSIS

3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS

4.1 COVID-19 ANALYSIS

5.1 GLOBAL DRUG DISCOVERY SOFTWARE MARKET, SALES AREA, TYPE

5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL DRUG DISCOVERY SOFTWARE MARKET

7.1 GLOBAL DRUG DISCOVERY SOFTWARE MARKET SIZE AND SHARE (2018-2031) (USD MILLION)

8.1 GLOBAL DRUG DISCOVERY SOFTWARE MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

8.2 GLOBAL DRUG DISCOVERY SOFTWARE MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

9.1 GLOBAL DRUG DISCOVERY SOFTWARE MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

9.2 GLOBAL DRUG DISCOVERY SOFTWARE MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

10.1 GLOBAL DRUG DISCOVERY SOFTWARE MARKET SIZE AND SHARE BY REGION (2018-2023) (USD MILLION)

10.2 GLOBAL DRUG DISCOVERY SOFTWARE MARKET SIZE AND SHARE BY REGION (2024-2031) (USD MILLION)

11.1 NORTH AMERICA DRUG DISCOVERY SOFTWARE MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

11.2 NORTH AMERICA DRUG DISCOVERY SOFTWARE MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

11.3 NORTH AMERICA DRUG DISCOVERY SOFTWARE MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

11.4 NORTH AMERICA DRUG DISCOVERY SOFTWARE MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

11.5 NORTH AMERICA DRUG DISCOVERY SOFTWARE MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

11.6 NORTH AMERICA DRUG DISCOVERY SOFTWARE MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

12.1 EUROPE DRUG DISCOVERY SOFTWARE MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

12.2 EUROPE DRUG DISCOVERY SOFTWARE MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

12.3 EUROPE DRUG DISCOVERY SOFTWARE MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

12.4 EUROPE DRUG DISCOVERY SOFTWARE MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

12.5 EUROPE DRUG DISCOVERY SOFTWARE MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

12.6 EUROPE DRUG DISCOVERY SOFTWARE MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

13.1 ASIA PACIFIC DRUG DISCOVERY SOFTWARE MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

13.2 ASIA PACIFIC DRUG DISCOVERY SOFTWARE MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

13.3 ASIA PACIFIC DRUG DISCOVERY SOFTWARE MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

13.4 ASIA PACIFIC DRUG DISCOVERY SOFTWARE MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

13.5 ASIA PACIFIC DRUG DISCOVERY SOFTWARE MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

13.6 ASIA PACIFIC DRUG DISCOVERY SOFTWARE MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

14.1 LATIN AMERICA DRUG DISCOVERY SOFTWARE MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)/p>

14.2 LATIN AMERICA DRUG DISCOVERY SOFTWARE MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

14.3 LATIN AMERICA DRUG DISCOVERY SOFTWARE MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

14.4 LATIN AMERICA DRUG DISCOVERY SOFTWARE MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

14.5 LATIN AMERICA DRUG DISCOVERY SOFTWARE MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

14.6 LATIN AMERICA DRUG DISCOVERY SOFTWARE MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

15.1 MIDDLE EAST & AFRICA DRUG DISCOVERY SOFTWARE MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

15.2 MIDDLE EAST & AFRICA DRUG DISCOVERY SOFTWARE MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

15.3 MIDDLE EAST & AFRICA DRUG DISCOVERY SOFTWARE MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

15.4 MIDDLE EAST & AFRICA DRUG DISCOVERY SOFTWARE MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

15.5 MIDDLE EAST & AFRICA DRUG DISCOVERY SOFTWARE MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

15.6 MIDDLE EAST & AFRICA DRUG DISCOVERY SOFTWARE MARKET SIZE AND SHARE BY APPLICATION (2024-2031)< (USD MILLION)/p>

16.1 Epocrates (United States)

  16.1.1 COMPANY DETAILS

  16.1.2 FINANCIALS (USD MILLION)

  16.1.3 PRODUCT SUMMARY

  16.1.4 RECENT DEVELOPMENTS

16.2 Thermo Scientific Nautilus LIMS (United States)

16.3 ChemDraw (PerkinElmer) (United States)

16.4 MicroTracker (Norway)

16.5 DrugPatentWatch (United States)

16.6 AutoDock (Scripps Research) (United States)

16.7 Collaborative Drug Discovery Inc. (United States)

16.8 DrugDev Spark (United States)

16.9 DSG Drug Safety (United States)

16.10 PEPID PDC (United States)

16.11 Schrodinger Discovery Informatics Suite (United States)

16.12 Advera Health (United States)

16.13 American Gene Technologies (United States)

16.14 Aurora Drug Discovery Software (United States)

16.15 BIOVIA Discovery Studio (United States)

18.1 METHODOLOGY

18.2 RESEARCH DATA SOURCE

  18.2.1 SECONDARY DATA

  18.2.2 KEY DATA FROM SECONDARY

  18.2.3 PRIMARY DATA

  18.2.4 KEY DATA FROM PRIMARY

  18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS

  18.2.6 MARKET ESTIMATION

  18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH

  18.2.8 LEGAL DISCLAIMER

Market Segments

By Application
Pharmaceutical Industry
Biotechnology Industry

By Deployment Mode
Cloud Based
Web Based

By Organization Size
Small & Medium Size Organizations
Large Organizations

By End Users
R&D scientists
Clinical trial organizers, managers, analysts

Companies

Epocrates (United States)
Thermo Scientific Nautilus LIMS (United States)
ChemDraw (PerkinElmer) (United States)
MicroTracker (Norway)
DrugPatentWatch (United States)
AutoDock (Scripps Research) (United States)
Collaborative Drug Discovery Inc. (United States)
DrugDev Spark (United States)
DSG Drug Safety (United States)
PEPID PDC (United States)
Schrodinger Discovery Informatics Suite (United States)
Advera Health (United States)
American Gene Technologies (United States)
Aurora Drug Discovery Software (United States)
BIOVIA Discovery Studio (United States)

BROWSE INDUSTRY

  1. Consumer Goods
  2. Healthcare
  3. Food & Beverage
  4. Heavy Industry
  5. Service Industries
  6. FMCG
  7. Life Sciences
  8. Technology & Media
  9. Machinery & Equipment

    WHY CHOOSE US

  •   PROACTIVE
  • We manage our resources 24/7 to identify issues and address them before they become problems.

  •   QUALITY & RELIABILITY
  • We are committed to providing reliable and highly accurate data with an excellent quality control system.

  •   GLOBAL OUTREACH
  • 6 Major regions and 40+ countries level analysis accomplished.

  •   COMPETITIVE PRICING
  • Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.